Name: Systemic lupus erythematosus
Creator: Daniel J, Wallace
Keywords: 03 medical and health sciences, 0302 clinical medicine, Animals, Humans, Lupus Erythematosus, Systemic, Prognosis, Immunosuppressive Agents, 3. Good health

descriptionPublicationkeyboard_double_arrow_right Article , Part of book or chapter of book , Other literature type 01 Jan 2002Publisher:PorticoJournal:Drugs of Today, volume 38, page 259 (issn: 1699-4019,

Authors: Daniel J, Wallace;

doi: 10.1358/dot.2002.38.4.765369 , 10.1016/b978-012373947-6/00667-x , 10.1016/b978-012373947-6.00667-x

pmid: 12532194

Systemic lupus erythematosus

- Summary
- Subjects
- Metrics

Abstract

Systemic lupus erythematosus is a pleomorphic, autoimmune disorder of unknown cause that can afflict all parts of the body. New insights into its pathogenesis, the employment of preventive measures and combinations of immunosuppressive therapy, as well as the introduction of biologics, are beginning to alter the prognosis and improve the quality of life for individuals with this serious disease.

Related Organizations

University of California, Los Angeles
United States

Keywords

Animals, Humans, Lupus Erythematosus, Systemic, Prognosis, Immunosuppressive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	6
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average